Onward Medical N.V (ONWD) | Stock Overview & Key Data
Onward Medical N.V. | Mid-cap | Healthcare
Onward Medical N.V. | Mid-cap | Healthcare
Onward Medical N.V Performance Comparison
Stock Range
Today's Range
Low: €5.14
High: €5.38
on September 18, 2025
52 Week Range
Low: €3.49
High: €7.24
on April 7, 2025
on January 29, 2025
All-Time High: €13.28 on October 18, 2021
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Key Statistics
Market Cap
€245.2M
EPS
-0.74
P/E Ratio (TTM)
-6.48
Forward P/E
-4.65
P/B Ratio
8.34
PEG Ratio
N/A
Div. Yield
N/A
ROE
-167.80%
Beta
0.951
Debt to Equity
54.33
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-1,685.49%
Profit Margin
90.39%
Returns and Earnings
Return on Assets (TTM)
-43.66%
Return on Equity (TTM)
-167.80%
EBITDA
€-35.7M
Net Income (TTM)
€-38.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.06
Quarterly Revenue Growth (YoY)
469.70%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Onward Medical N.V ONWD | 245.24M Mid-cap | 0.19% | 24.15% | 16.29% | 9.83% | -3.75% | 5.11% | -16.42% | -59.65% |
| Argenx SE ARGX | 39.22B Large-cap | -5.56% | 7.85% | 30.80% | 9.45% | 1.24% | 28.30% | 73.61% | 195.04% |
| UCB S.A UCB | 39.10B Large-cap | -3.00% | 4.12% | 31.16% | 11.75% | 6.35% | 25.08% | 193.06% | 108.12% |
| Hyloris HYL | 177.52M Mid-cap | -3.77% | -4.38% | 4.44% | -4.38% | -4.38% | 6.62% | -52.19% | -40.00% |
| European Medical ALEMS | 19.79M Small-cap | 16.28% | 6.38% | 14.94% | -19.35% | -16.67% | -26.79% | -87.65% | -92.88% |
| Celyad Oncology S.A CYAD | 14.28M Small-cap | -6.25% | -23.08% | -23.08% | -51.61% | -55.22% | 15.38% | -82.86% | -96.17% |
Ownership & Short Interest
Insider Ownership
24.47%
Institutional Ownership
30.02%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
129K
Average 90-Day Volume
127K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ONWD's 52-week high and low?
- In the last 52 weeks, Onward Medical N.V reached a high of €7.24 (on January 29, 2025) and a low of €3.49 (on April 7, 2025).
- What is the market cap and P/E ratio for ONWD?
- Curious about Onward Medical N.V's size and valuation? Its market capitalization stands at 245.24M. When it comes to valuation, the P/E ratio (trailing twelve months) is -6.48, and the forward P/E (looking ahead) is -4.65.
- Does ONWD pay dividends? If so, what's the yield?
- As for dividends, Onward Medical N.V isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Onward Medical N.V's main competitors or similar companies to consider before investing?
When looking at Onward Medical N.V, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Argenx SE
ARGX39.22B Healthcare Biotechnology 28.30% 73.61% UCB S.A
UCB39.10B Healthcare Biotechnology 25.08% 193.06% Hyloris
HYL177.52M Healthcare Biotechnology 6.62% -52.19% European Medical
ALEMS19.79M Healthcare Biotechnology -26.79% -87.65% Celyad Oncology S.A
CYAD14.28M Healthcare Biotechnology 15.38% -82.86% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Onward Medical N.V.? (e.g., ROE, Debt/Equity)
- To get a sense of Onward Medical N.V's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -167.80%, the Debt to Equity ratio from the most recent quarter is 54.33, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ONWD?
- Looking at Onward Medical N.V's growth, its revenue over the trailing twelve months (TTM) was €3M. Compared to the same quarter last year (YoY), quarterly revenue grew by 469.70%, and quarterly earnings saw a YoY growth of N/A.
- How much of ONWD stock is held by insiders and institutions?
- Wondering who owns Onward Medical N.V stock? Company insiders (like executives and directors) hold about 24.47% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 30.02%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.